Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combined androgen blockade.

E D Crawford1

  • 1Division of Urology, University of Colorado School of Medicine, Denver.

Urology
|October 1, 1989
PubMed
Summary
This summary is machine-generated.

Combined therapy for advanced prostate cancer shows advantages over monotherapy. Recent National Cancer Institute (NCI) study results suggest benefits, though adrenal androgen suppression remains debated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics.

Nature communications·2022
Same author

Corroborating evidence refutes batch effect as explanation for fetal bacteria.

Microbiome·2021
Same author

Viable bacterial colonization is highly limited in the human intestine in utero.

Nature medicine·2020
Same author

Acute West Nile Virus Meningoencephalitis Diagnosed Via Metagenomic Deep Sequencing of Cerebrospinal Fluid in a Renal Transplant Patient.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications.

Genome biology·2016
Same author

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2013
Same journal

"Editorial Comment on "Vaginal Estrogen Prescription is Associated with Reduced Rates of Serious Adverse Outcomes in Women of All Age Groups With Recurrent Urinary Tract Infection: An Epic Cosmos Database Analysis".

Urology·2026
Same journal

The True Oral History of Buccal Mucosal Grafts for Male Urethral Stricture Repair.

Urology·2026
Same journal

Preventing Postpartum Pelvic Floor Dysfunction: Clinical Evidence and Policy Gaps in U.S. Coverage of Pelvic Floor Muscle Therapy.

Urology·2026
Same journal

Editorial Comment on "Through the Eyes of the Applicant: A Qualitative Study of the Urology Residency Match".

Urology·2026
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
See all related articles

Area of Science:

  • Oncology
  • Urology

Background:

  • Advanced prostate cancer treatment often involves androgen suppression.
  • The efficacy of combined androgen suppression versus monotherapy remains a subject of debate.
  • Previous studies from the 1980s yielded conflicting results regarding combined therapy's value.

Purpose of the Study:

  • To evaluate the effectiveness of combined androgen suppression therapy in advanced prostate cancer.
  • To compare combined therapy outcomes against monotherapy (surgical or chemical castration).

Main Methods:

  • A randomized, controlled, multicenter intergroup study was conducted.
  • The study was sponsored by the U.S. National Cancer Institute (NCI).

Main Results:

Related Experiment Videos

  • Recent findings from the NCI-sponsored study suggest combined therapy offers advantages over monotherapy.
  • The study provides new data on the efficacy of combined therapy for advanced prostate cancer.

    • Conclusions:

    • Combined androgen suppression therapy may offer benefits in treating advanced prostate cancer.
    • Further research and debate continue regarding the role of adrenal androgen suppression agents in prostate cancer treatment.